Menu

Village Global

The World is a Village

in

MHRA Approves First T1D Immunotherapy in UK

Source link : https://newshealth.biz/health-news/mhra-approves-first-t1d-immunotherapy-in-uk/

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved teplizumab (Tzield, Aventis Pharma Limited) as the UK’s first immunotherapy for type 1 diabetes (T1D). The drug is licensed for adults and children aged 8 years and older with stage 2 T1D to delay progression to stage 3. Teplizumab was approved in the US in […]

The post MHRA Approves First T1D Immunotherapy in UK first appeared on News Health.

—-

Author : News Health

Publish date : 2025-08-15 10:54:00

Copyright for syndicated content belongs to the linked Source.

—-

12345678

Exit mobile version